Limiting systemic endocrine overtreatment in postmenopausal breast cancer patients with an ultralow classification of the 70-gene signature

被引：0
|
作者：
M. Opdam
V. van der Noort
M. Kleijn
A. Glas
I. Mandjes
S. Kleiterp
F. S. Hilbers
D. T. Kruger
A. D. Bins
P. C. de Jong
P. P. J. B. M. Schiphorst
T. van Dalen
B. Flameling
R. C. Rietbroek
A. Beeker
S. M. van den Heiligenberg
S. D. Bakker
A. N. M. Wymenga
I. M. Oving
R. M. Bijlsma
P. J. van Diest
J. B. Vermorken
H. van Tinteren
S. C. Linn
机构：
[1] Netherlands Cancer Institute,Department of Molecular Pathology
[2] Netherlands Cancer Institute,Biometrics Department
[3] Agendia NV,Medical Affairs
[4] Amsterdam UMC,Department of Medical Oncology
[5] Sint-Antonius Hospital,Department of Medical Oncology
[6] Streekziekenhuis Koningin. Beatrix,Department of Internal Medicine
[7] Diakonessenhuis,Department of Surgery
[8] OLVG,Department of Medical Oncology
[9] Red Cross Hospital,Department of Internal Medicine
[10] Spaarne Gasthuis,Department of Medical Oncology
[11] Dijklander Ziekenhuis,Department of Medical Oncology
[12] Zaans Medisch Centrum,Department of Internal Medicine
[13] Medisch Spectrum Twente,Department of Medical Oncology
[14] Ziekenhuisgroep Twente,Department of Medical Oncology
[15] UMCU,Department of Medical Oncology
[16] UMCU,Department of Pathology
[17] University Hospital Antwerp (UZA),Department of Medical Oncology
[18] University of Antwerp,Faculty of Medicine and Health Sciences
[19] Trial and Data Center,Department of Medical Oncology
[20] Princess Maxima Centre for Pediatric Oncology,undefined
[21] Netherlands Cancer Institute,undefined
来源：
Breast Cancer Research and Treatment | 2022年 / 194卷
关键词：
Early breast cancer; Postmenopausal; MammaPrint 70-gene signature; Prognosis; Endocrine treatment; Overtreatment;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：265 / 278
页数：13
相关论文
共 50 条
  • [31] The 70-gene MammaPrint signature is predictive for chemotherapy benefit in early breast cancer
    Knauer, M.
    Straver, M.
    Rutgers, E.
    Bender, R.
    Cardoso, F.
    Mook, S.
    van de Vijver, M.
    Saghatchian, M.
    Koornstra, R.
    Bueno-de-Mesquita, J.
    Rodenhuis, S.
    Linn, S.
    van 't Veer, L.
    BREAST, 2009, 18 : S36 - S37
  • [32] Oncology "70-Gene Signature" - Test facilitates the Therapy Finding of Breast Cancer
    Lichert, Frank
    GEBURTSHILFE UND FRAUENHEILKUNDE, 2016, 76 (12)
  • [33] Use in current clinical practice of 70-gene signature in early breast cancer
    Bighin, Claudia
    Del Mastro, Lucia
    Canavese, Giuseppe
    Carli, Franca
    Taveggia, Paola
    Levaggi, Alessia
    Giraudi, Sara
    Pronzato, Paolo
    INTERNATIONAL JOURNAL OF CANCER, 2010, 127 (11) : 2736 - 2737
  • [34] Combining method of detection and 70-gene signature for enhanced prognostication of breast cancer
    Lopes Cardozo, J. M. N.
    Schmidt, M. K.
    van 't Veer, L. J.
    Cardoso, F.
    Poncet, C.
    Rutgers, E. J. T.
    Drukker, C. A.
    BREAST CANCER RESEARCH AND TREATMENT, 2021, 189 (02) : 399 - 410
  • [35] The predictive value of the 70-gene signature for adjuvant chemotherapy in early breast cancer
    Michael Knauer
    Stella Mook
    Emiel J. T. Rutgers
    Richard A. Bender
    Michael Hauptmann
    Marc J. van de Vijver
    Rutger H. T. Koornstra
    Jolien M. Bueno-de-Mesquita
    Sabine C. Linn
    Laura J. van ’t Veer
    Breast Cancer Research and Treatment, 2010, 120 : 655 - 661
  • [36] Clinical and molecular characteristics of estrogen receptor-positive ultralow risk breast cancer tumors identified by the 70-gene signature
    Johansson, Annelie
    Yu, Nancy Y.
    Iftimi, Adina
    Tobin, Nicholas P.
    't Veer, Laura
    Nordenskjold, Bo
    Benz, Christopher C.
    Fornander, Tommy
    Perez-Tenorio, Gizeh
    Stal, Olle
    Esserman, Laura J.
    Yau, Christina
    Lindstrom, Linda S.
    INTERNATIONAL JOURNAL OF CANCER, 2022, 150 (12) : 2072 - 2082
  • [37] The 70-gene prognosis signature predicts early metastasis in breast cancer patients between 55 and 70 years of age
    Mook, S.
    Schmidt, M. K.
    Weigelt, B.
    Kreike, B.
    Eekhout, I.
    van de Vijver, M. J.
    Glas, A. M.
    Floore, A.
    Rutgers, E. J. T.
    't Veer, L. J. Van
    ANNALS OF ONCOLOGY, 2010, 21 (04) : 717 - 722
  • [38] French cost effectiveness study of the MammaPrint 70-gene signature in early stage breast cancer patients
    Zarca, D.
    Stork-Sloots, L.
    de Snoo, F.
    Brink, G.
    Dervaux, Y.
    Boubli, L.
    EJC SUPPLEMENTS, 2009, 7 (02): : 310 - 310
  • [39] Validation of the 70-gene signature test (MammaPrint) to identify patients with breast cancer aged ≥70 years with ultralow risk of distant recurrence: A population-based cohort study
    Mansani, Fabio P.
    Freitas-Junior, Ruffo
    JOURNAL OF GERIATRIC ONCOLOGY, 2023, 14 (05)
  • [40] 70-Gene Signature as an Aid to Treatment Decisions in Early-Stage Breast Cancer
    Cardoso, F.
    van't Veer, L. J.
    Bogaerts, J.
    Slaets, L.
    Viale, G.
    Delaloge, S.
    Pierga, J. -Y.
    Brain, E.
    Causeret, S.
    DeLorenzi, M.
    Glas, A. M.
    Golfinopoulos, V.
    Goulioti, T.
    Knox, S.
    Matos, E.
    Meulemans, B.
    Neijenhuis, P. A.
    Nitz, U.
    Passalacqua, R.
    Ravdin, P.
    Rubio, I. T.
    Saghatchian, M.
    Smilde, T. J.
    Sotiriou, C.
    Stork, L.
    Straehle, C.
    Thomas, G.
    Thompson, A. M.
    van der Hoeven, J. M.
    Vuylsteke, P.
    Bernards, R.
    Tryfonidis, K.
    Rutgers, E.
    Piccart, M.
    NEW ENGLAND JOURNAL OF MEDICINE, 2016, 375 (08): : 717 - 729
12345